GW Pharmaceuticals says positive Sativex results published

GW Pharmaceuticals Plc said results of a clinical trial showing its Sativex experimental medicine relieved pain in cancer patients whose suffering wasn’t eased by strong opioids were published in the Journal of Pain and Symptom Management.